By James Giordano, PhD, as told to Kara Mayer Robinson
Over the last 20 years, we’ve seen major strides in the treatment options for major depressive disorder.
We now understand that depression isn’t the same for everyone. The idea is to identify and diagnose what’s happening in a person’s neurochemistry so we can target our treatment in a way that works specifically for them.
Advances in Evidence-Based Treatment
Drug therapy has come a long way in recent years. We’ve improved the scope and focus of drug therapy by developing more selective or specialized antidepressants and combining them in new ways, with fewer side effects.